Marcus & Millichap, Inc.
MMIOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $755.2M | $696.1M | $645.9M | $1.30B | $1.30B | $716.9M |
| Operating income | −$13.7M | −$32.9M | −$59.4M | $137.4M | $189.4M | $53.6M |
| Net income | −$1.9M | −$12.4M | −$34.0M | $104.2M | $142.5M | $42.8M |
| Total assets | $827.2M | $869.8M | $878.4M | $1.00B | $1.05B | $779.1M |
| Total liabilities | $224.1M | $239.0M | $233.1M | $290.2M | $348.9M | $232.3M |
| Equity | $603.1M | $630.8M | $645.3M | $713.5M | $696.3M | $546.8M |
| EPS (diluted) | $-0.05 | $-0.32 | $-0.88 | $2.59 | $3.55 | $1.08 |
| Shares out. | 38.9M | 38.4M | 39.2M | 39.7M | 39.4M | 39.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −1.8%
- Net margin
- −0.3%
- Return on equity
- −0.3%
- Return on assets
- −0.2%
- Return on capital (ROCE)
- −1.9%
- Liabilities / assets
- 27.1%
- Debt / equity
- 0.37×
- Book value / share
- $15.51
- Revenue growth (YoY)
- 8.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 5.82safe
- Accruals / assets
- −8.3%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 5 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Pzena Investment Management LlcPassive (13G)Apr 17, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Reinhart Partners, Llc.Passive (13G)Feb 12, 2026
- Royce & Associates LpPassive (13G)Apr 30, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Parker John DavidOfficer — EVP & COO | May 8, 2026 | Option exercise | 2,000 | — |
| Martin LauraleeDirector | Apr 30, 2026 | Grant | 2,698 | $27.79 |
| Marcus George MDirector | Apr 30, 2026 | Grant | 2,698 | $27.79 |
| Watters Don C.Director | Apr 30, 2026 | Grant | 2,698 | $27.79 |
| Shaheen George TDirector | Apr 30, 2026 | Grant | 2,698 | $27.79 |
| Lawrence Norma J.Director | Apr 30, 2026 | Grant | 2,698 | $27.79 |
| Mcclanahan Nicholas F.Director | Apr 30, 2026 | Grant | 2,698 | $27.79 |
| English Dixon ColleteDirector | Apr 30, 2026 | Grant | 2,698 | $27.79 |
| Nadji HessamOfficer — Chief Executive Officer | Mar 13, 2026 | Sell | 1,300 | $25.60 |
| Nadji HessamOfficer — Chief Executive Officer | Mar 10, 2026 | Option exercise | 14,400 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 956,614 | 3.7 | +3.2% |
| Apr 30, 2026 | 926,742 | 4.9 | +26.8% |
| Apr 15, 2026 | 730,683 | 4.5 | +0.8% |
| Mar 31, 2026 | 725,044 | 2.4 | -6.2% |
| Mar 13, 2026 | 773,256 | 2.5 | +39.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 7, 2026
- Shareholder voteMay 1, 2026
- Results of operationsFeb 13, 2026
- Results of operationsNov 7, 2025
- Results of operationsAug 7, 2025
- Director / officer changeJun 9, 2025
- Results of operations · Shareholder voteMay 7, 2025
- Director / officer changeApr 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.